SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and break below key support levels are dominating discussion, with traders pointing to leveraged-long liquidations and broader risk-off pressure across crypto and tech as possible contributors. The community is split between warnings of further downside and calls to buy an oversold dip or watch for support.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas reiterated that topline results from its Phase 3 REGAL trial of GPS in AML are expected in November after the trial reached its required event milestone, drawing attention to the pending binary readout. Traders are broadly excited about the prospect of positive data and a short squeeze, while speculation about a leak or buyout remains unconfirmed and skeptics stress that results have not been released and the trial outcome is uncertain.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints about work interruptions and concern that the prolonged disruption could damage trust or pressure the stock. Some traders speculated about a cyberattack, but the cause was not confirmed, and others questioned why shares held relatively steady.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline toward the $1 support level amid a broader crypto selloff is dominating discussion, with traders pointing to Bitcoin weakness, inflation and rate concerns, and liquidations. Bears warn of further downside and question Ripples ability to provide catalysts, while some holders view the drop as a buying opportunity and continue accumulating.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Weakness in Ethereum and broader crypto-linked stocks is weighing on BitMine, while traders also criticize its underperformance and question managements spending, transparency, and buybacks. Some see the stocks discount to its crypto holdings as a buying opportunity, but bearish posts argue falling ETH prices can overwhelm any support from repurchases.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure as Bitcoin and broader crypto markets sell off, with traders highlighting COINs repeated new lows and weak performance even when Bitcoin stabilizes. Bearish calls dominate, though some see the decline as oversold and are buying the dip.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ET Family Business Awards: Torrent Pharma drives growth through acquisitions and innovation

Aman Mehta is guiding Torrent Pharmaceuticals through a significant period of growth and strategic change. He is driving the company's expansion through acquisitions, notably the purchase of JB Chemicals. This move positions Torrent Pharma for a potential entry into India's top five pharmaceutical companies. Mehta's leadership also emphasizes organic growth, strategic in-licensing, and a strong focus on research and development.

JB Chemicals & Pharmaceuticals Shifts Registered Office from Maharashtra to Gujarat

JB Chemicals & Pharmaceuticals Ltd. ( ($IN:JBCHEPHARM) ) has provided an announcement. JB Chemicals & Pharmaceuticals Ltd. has shifted its register...

Torrent Pharma Completes JB Chemicals Acquisition, Becomes Promoter with 46.39% Stake

… Disclosure Requirements) Regulations, 2015. Torrent Pharmaceuticals is listed on the BSE … the symbol TORNTPHARM. Torrent Pharmaceuticals stated that the acquisition aligns … disclosure on record. Torrent Pharmaceuticals Limited is headquartered in Ahmedabad …

JB Pharma Q3 FY26 Profit Jumps 22% to Rs 198 Crore on Strong Domestic, International Growth

… continued to outperform the Indian pharmaceutical market, led by broad-based … December 2025 data, JB Pharma outperformed the Indian Pharmaceutical Market (IPM), clocking … core operations. JB Chemicals & Pharmaceuticals Ltd, established in 1976, is …

JB Chemicals & Pharmaceuticals Ltd records revenue growth of 11% to INR 1065 crores in Q3 FY26

… & Pharmaceuticals Ltd (JB Pharma ), one of the fastest growing pharmaceutical companies in … and Wholetime Director, JB Pharma stated "JB Pharma' ;s domestic formulations … once again outperformed the Indian pharmaceutical market, driven by broad-based …

Q3 Results Today Live: Federal Bank Q3 profit rises, Reliance, Wipro, Tech Mahindra, Polycab India, L&T Finance, Sobha, JB Chemicals to announce Q3 results, Infosys shares soar

… EPC Irrigation, Kesoram Industries, Emerald Finance , Chembond Material Technologies, Neptune … Key Corporation, Mapro Industries, Viji Finance , and Tree House Education and … of India, Federal Bank, Geojit Financial Services, JB Chemicals & Pharmaceuticals …

Torrent Pharma lines up mega $1.4 billion acquisition-funding bond sale, bankers say

Torrent Pharmaceuticals is set to raise 125 billion rupees via bond sales in January. This funding will support its acquisition of a controlling stake in JB Chemicals & Pharmaceuticals. The deal is expected to boost Torrent Pharma's market share significantly. This move highlights a growing trend of domestic bond market financing for acquisitions in India.

JB Pharma posts ₹1,085 crore in Q2 FY26; net profit up 19%

Mumbai: JB Chemicals & Pharmaceuticals (JB Pharma ) ended the second quarter of … results Nikhil Chopra, CEO, JB Pharma said, “Our focus on driving …

JB Chemicals Relocates Registered Office to Gujarat

The latest update is out from JB Chemicals & Pharmaceuticals Ltd. ( ($IN:JBCHEPHARM) ). JB Chemicals & Pharmaceuticals Limited has announced the re...

India Pharma, Healthcare Deals Jump 166% In Q3 2025: Grant Thornton

India's pharma and healthcare sector saw 72 deals worth USD 3.5 billion in Q3 2025, led by Torrent Pharma's USD 1.4 billion JB Chemicals stake and strong M&A and IPO activity.

Indian Markets Cool After A Four-Day Rally, Nifty Ends Above 25,500; Midcaps Shine

Equity

Neutral Sentiment

Indian equity markets took a breather, snapping a four-day winning streak, with the Nifty index ending above the 25,500 level.&nbsp;The Sensex fell 452 points to close at 83,606, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> fell 120 points to finish at 25,517.Broader markets outperformed with the Nifty Midcap index gaining for the seventh straight session. The Midcap and Smallcap indices rose by over 0.5%.&nbsp;The retail investor sentiment surrounding the Nifty 50 remained ‘bullish’ on Stocktwits.&nbsp;<figure class="image"><img style="aspect-ratio:806/101;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_30_162818_png_f79d596da9.webp" alt="Screenshot 2025-06-30 162818.png" width="806" height="101"><figcaption>Nifty sentiment and message volume on June 30 as of 4:30 pm IST | source: Stocktwits</figcaption></figure>Sectorally, it was a mixed bag, with auto, FMCG, metals, and real estate stocks witnessing selling pressure. The PSU bank index rallied over 2%. This was after the Finance Ministry directed state-owned lenders to monetize their stakes in subsidiaries through IPOs or strategic stake sales.&nbsp;Karnataka Bank ended 6% lower after the bank's CEO and Executive Director resigned from their positions, citing personal reasons.IDBI Bank shares gained 2% on reports that the government is gearing up to invite financial bids for the lender.&nbsp;IndusInd Bank also rose 2% on news reports that the lender has submitted a shortlist of three senior bankers to the Reserve Bank of India (RBI) for consideration as its next chief executive officer.&nbsp;<a href="https://stocktwits.com/symbol/JBCHEPHARM.NSE">JB Pharma shares</a> ended 7% lower after <a href="https://stocktwits.com/symbol/TORNTPHARM.NSE">Torrent Pharma</a> bought a 46.39% stake in the company from private equity giant KKR for ₹11,917 crore. They will also make an open offer to buy 26% more from public shareholders at ₹1,639.18 per share. JB Pharma slipped as investors priced in the 9% discount on the open offer, while Torrent rose 2% on the deal positives and aggressive consolidation.&nbsp;<a href="https://stocktwits.com/symbol/APLLTD.NSE">Alembic Pharma</a> surged 6% after it received USFDA approval for a key cancer drug. Timken rose 5% after it announced that commercial production has commenced at its new manufacturing facility in Bharuch.&nbsp;Jyoti CNC ended 6% lower on the back of a large block deal. And <a href="https://stocktwits.com/symbol/WAAREEENER.NSE">Waaree Energies</a> surged 7% on a fresh order win.&nbsp;<a href="https://stocktwits.com/symbol/RAYMOND.NSE">Raymond</a> rallied 14% ahead of its real estate arm, Raymond Realty’s listing tomorrow.&nbsp;Globally, European markets traded lower, and Dow Futures indicated a positive opening for Wall Street.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

The Bombay Stock Exchange building is in Mumbai, India, on April 8, 2025. (Photo by Indranil Aditya/NurPhoto via Getty Images)

Broader markets outperformed, led by gains in PSU banks and midcaps, reflecting investor rotation. 

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

JBCHEPHARM.NSE Fundamentals